JAZZ Venture Partners — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Cadence Neurosciencecadenceneuro.com inSeries A · May 2023 · $26M✓ verified

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsLumira Ventures Angelini Ventures F-Prime Capital Iaso Ventures Mayo Clinic Ventures

Tomatotomato.ai inAug 2023

Tomato.ai developed AI technology for enhancing human speech in real time, aimed at enterprise environments and communications platforms.

AI & Machine LearningDeep TechEnterprise SoftwareDanville, US

Ofer Ronen(Founder)inJames Fan(Founder)inYe Jia(Executive Officer, Promoter)

Co-investorsCardumen Capital Creative HQ — The Incubator Gaingels Point72 Ventures Recursive Ventures

Zus Healthzushealth.com in 𝕏Series A · Mar 2023 · $40M

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)inJonathan S. Bush(Founder)

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)in

Co-investorsAdvection Growth Capital Alumni Ventures Andreessen Horowitz F-Prime Capital Martin Ventures Maverick Ventures +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.